New Pharmaceutical Product

Genus PLC
15 December 2004


For Immediate Release                                      15 December 2004



                                    Genus plc

                           New Pharmaceutical Product


Genus plc ('Genus') the Global bovine genetics company has concluded negotiation
for a new veterinary product for its veterinary sales and marketing business,
Animalcare.



The agreement is with a large European based pharmaceutical supplier and gives
Animalcare the right to develop and register a generic version of an established
companion animal medicine in the UK and certain other countries in the EU.



Animalcare expects, at product maturity, to gain a significant share of the
market for this product which is currently around £5m p.a. in the UK alone.



Richard Wood, Chief Executive of Genus, commented:



'I am delighted to announce this important development which confirms that
Animalcare is making good progress in its acquisition of high value
pharmaceutical products to extend its range.'



Contact:


Richard Wood, Chief Executive                        Tel: [phone]
David Timmins, Finance Director                      Tel: [phone]

Charles Ryland/Suzanne Brocks                        Tel: [phone]
Buchanan Communications




                      This information is provided by RNS
            The company news service from the London Stock Exchange